As a distributor in the human healthcare sector, Harley’s Limited is committed to supporting the safety of the products we distribute to patients. This responsibility involves actively monitoring and reporting any adverse events experienced by patients to the respective manufacturers and regulatory authorities, when applicable.
This practice, known as pharmacovigilance (PV), helps Harley’s Limited, our suppliers and competent regulatory authorities, such as the Ministry of Health and Wellness in Mauritius and other relevant foreign authorities, to effectively manage potential product risks and support public health. To fulfill our PV responsibilities, we may need to collect and process personal data relating to patients and/or the individuals reporting adverse events. This data is necessary for accurate and timely reporting to manufacturers and regulatory authorities. Any personal information provided through our adverse event reporting forms is handled with strict confidentiality and used solely for follow-up and compliance purposes.
Fill in the pharmacovigilance (PV) reporting form by providing all the necessary details. Note that all the fields marked with an asterisk (*) are required to be filled out.